Treatment of Acute Myeloid Leukaemia according to the Hammersmith Protocol: Preliminary ReportBr Med J 1973; 3 doi: https://doi.org/10.1136/bmj.3.5880.567 (Published 15 September 1973) Cite this as: Br Med J 1973;3:567
- W. Paolino,
- L. Resegotti,
- M. Rossi,
- V. Infelise
A preliminary report is given of a trial of the T.R.A.P. regimen (thioguanine, rubidomycin, cytosine arabinoside, and prednisolone) for the treatment of acute myeloid leukaemia. Out of 27 patients treated 13 (48·1%) obtained complete remission. The treatment was well tolerated and produced especially good results in elderly patients.